K
KalVista Pharmaceuticals D
D
KALV
8.81000
USD
0.46
(5.45%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
435,372,457
المقالات
العنوان: KalVista Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.